Capricor Therapeutics | CAPR - Sales Revenues

Stock Price
34.71
Daily Change
-0.01 -0.03%
Monthly
13.58%
Yearly
260.07%
Q2 Forecast
30.35

Capricor Therapeutics reported $11.13M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Bioline Rx USD 427K 123K Sep/2025
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Cipla INR 75.18B 710M Dec/2025
Cytokinetics USD 17.76M 15.83M Dec/2025
Geron USD 48.02M 820K Dec/2025
Grifols EUR 2.34B 33.3M Mar/2026
J&J USD 24.1B 500M Mar/2026
Plus Therapeutics USD 1.37M 30K Dec/2025
Prothena USD 21K 2.4M Dec/2025
PTC Therapeutics USD 164.7M 46.3M Dec/2025
Sarepta Therapeutics USD 442.9M 43.5M Dec/2025